Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis
Top Cited Papers
- 16 December 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 164 (4), 776-784
- https://doi.org/10.1111/j.1365-2133.2010.10185.x
Abstract
Background There have been conflicting data regarding the prevalence and clinicopathological characteristics of BRAF and NRAS mutations in primary cutaneous melanoma. Objectives To solve this controversy, this study used a meta‐analysis to evaluate the frequencies of BRAF and NRAS mutations, and the relationship between these mutations and clinicopathological parameters of cutaneous melanoma. Methods Data from studies published between 1989 and 2010 were combined. The BRAF and NRAS mutations were reported in 36 and 31 studies involving 2521 and 1972 patients, respectively. The effect sizes of outcome parameters were calculated by odds ratios (OR). Results BRAF and NRAS mutations were reported in 41% and 18% of cutaneous melanomas, respectively. The mutations were associated with histological subtype and tumour site, but not with age and sex. The BRAF mutation was frequently detected in patients with superficial spreading melanoma (OR = 2·021; P < 0·001) and in melanomas arising in nonchronic sun‐damaged skin (OR = 2·043; P = 0·001). In contrast, the NRAS mutation was frequently evident in patients with nodular melanoma (OR = 1·894; P < 0·001) and in melanomas arising in chronic sun‐damaged skin (OR = 1·887; P = 0·018). Conclusions This pooled analysis shows that the incidences of BRAF and NRAS mutations in cutaneous melanomas differ according to histological type and tumour location based on the degree of sun exposure.This publication has 46 references indexed in Scilit:
- Role of key-regulator genes in melanoma susceptibility and pathogenesis among patients from South ItalyBMC Cancer, 2009
- Frequencies of NRAS and BRAF Mutations Increase from the Radial to the Vertical Growth Phase in Cutaneous MelanomaJournal of Investigative Dermatology, 2009
- Lack of Cytoplasmic ERK Activation Is an Independent Adverse Prognostic Factor in Primary Cutaneous MelanomaJournal of Investigative Dermatology, 2008
- MC1R Variants Increase Risk of Melanomas Harboring BRAF MutationsJournal of Investigative Dermatology, 2008
- Improving Melanoma Classification by Integrating Genetic and Morphologic FeaturesPLoS Medicine, 2008
- In melanocytic lesions the fraction of BRAFV600E alleles is associated with sun exposure but unrelated to ERK phosphorylationLaboratory Investigation, 2008
- Gene expression signature associated with BRAF mutations in human primary cutaneous melanomasMolecular Oncology, 2008
- Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body siteMolecular Oncology, 2007
- T1799A BRAF Mutation is Common in PUVA LentiginesJournal of Investigative Dermatology, 2006
- Mutations of the BRAF gene in human cancerNature, 2002